三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
抗血管靶向药2021年市场格局
抗血管靶向药2021年市场格局
竞争格局
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:61KB
图片尺寸:1836*894
同报告图片
/
4
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOiNr+eJqSAgICAgICB8IOW4guWcuuS7veminSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCDpmL/luJXmm7/lsLwgICB8IDQlICAgICAgIHwKfCDlronnvZfmm7/lsLwgICB8IDclICAgICAgIHwKfCDotJ3kvJDnj6DljZXmipcgfCA1NCUgICAgICB8Cnwg55Ge5oiI6Z2e5bC8ICAgfCAyMCUgICAgICB8Cnwg5LuR5LyQ5pu/5bC8ICAgfCA4JSAgICAgICB8Cnwg57Si5ouJ6Z2e5bC8ICAgfCA3JSAgICAgICB8CgrotYTmlpnmnaXmupDvvJpDUEEg5pWw5o2u77yM6KW/6YOo6K+B5Yi456CU5Y+R5Lit5b+D
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
所属报告:
中国生物制药-首次覆盖:研产销一体Bigpharma创新转型曙光重现-220616(36页).pdf
打包全文图表
相关数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
图15、全球武器装备出口总额重回高位(亿
收藏
行业数据
2026-07-30
原图定位
查看详情
图14、1992-2025年全球军费开支及同比增速
收藏
行业数据
2026-07-30
原图定位
查看详情
图22、2026E-2035E我国气象探测领域相控阵雷达市场规模(亿元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球人形机器人电池市场空间预测(万台,亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
2022-2026全球新增户储出货量(单位:GWh)
收藏
行业数据
2026-07-30
原图定位
查看详情
2025全球户储新增装机地区分布(%)
收藏
行业数据
2026-07-30
原图定位
查看详情
图37.《碧蓝航线》全球搜索热度
收藏
行业数据
2026-07-30
原图定位
查看详情
我国谐波减速器市场规模(亿元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球固态与半固态电池市场规模展望
收藏
行业数据
2026-07-30
原图定位
查看详情
全球固态/半固态电池正极材料市场空间(亿元)及需求(万吨)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球固态电池市场空间展望(亿元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球乳制品消费总量(百万吨)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品年人均消费支出(美
收藏
行业数据
2026-07-30
原图定位
查看详情
全球全年龄段奶粉年人均消费支出(美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
盐酸安罗替尼胶囊(福可维®)是公司首个抗肿瘤领域 1 类新药,公司拥有其在中国大陆进行临床开发和商业化的全部权益。该药物是口服多靶点酪氨酸激酶抑制剂,对血管新生相关受体 VEGFR 家族、PDGFR 家族、FGFR 家族同时具有较强的抑制作用,于 2018年 5 月获得了国家药品监督管理局(NMPA)的上市批准。目前主要竞品为其他小分子VEGFR 单抗包括阿帕替尼、索拉非尼、瑞戈非尼和仑伐替尼,以及大分子 VEGF 单抗贝伐珠单抗。
竞争格局
原图定位
当前图表所属:
中国生物制药-首次覆盖:研产销一体Bigpharma创新转型曙光重现-220616(36页).pdf
肝病领域重点品种销售预测
安尼可销售预测
安罗替尼销售测算
公司发展里程碑
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》